Burger Pascal M, Koudstaal Stefan, Dorresteijn Jannick A N, Savarese Gianluigi, van der Meer Manon G, de Borst Gert J, Mosterd Arend, Visseren Frank L J
Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
Department of Cardiology, Green Heart Hospital, Gouda, the Netherlands.
Int J Cardiol. 2023 May 15;379:66-75. doi: 10.1016/j.ijcard.2023.03.024. Epub 2023 Mar 11.
In patients with established cardiovascular disease (CVD), the relation between metabolic syndrome (MetS) and incident heart failure (HF) in the absence of diabetes mellitus (DM) is largely unknown. This study assessed this relation in non-diabetic patients with established CVD.
Patients from the prospective UCC-SMART cohort with established CVD, but without DM or HF at baseline were included (n = 4653). MetS was defined according to the Adult Treatment Panel III criteria. Insulin resistance was quantified using the homeostasis model of insulin resistance (HOMA-IR). The outcome was a first hospitalization for HF. Relations were assessed using Cox proportional hazards models adjusted for established risk factors: age, sex, prior myocardial infarction (MI), smoking, cholesterol, and kidney function.
During a median follow-up of 8.0 years, 290 cases of incident HF were observed (0.81/100 person years). MetS was significantly related to an increased risk of incident HF independent of established risk factors (hazard ratio [HR] 1.32; 95% confidence interval [CI] 1.04-1.68, HR per criterion 1.17; 95% CI 1.06-1.29), as was HOMA-IR (HR per standard deviation [SD] 1.15; 95% CI 1.03-1.29). Of the individual MetS components, only higher waist circumference independently increased the risk of HF (HR per SD 1.34; 95% CI 1.17-1.53). Relations were independent of the occurrence of interim DM and MI, and were not significantly different for HF with reduced vs preserved ejection fraction.
In CVD patients without a current diagnosis of DM, MetS and insulin resistance increase the risk of incident HF independent of established risk factors.
在已确诊心血管疾病(CVD)的患者中,代谢综合征(MetS)与无糖尿病(DM)情况下发生心力衰竭(HF)之间的关系在很大程度上尚不清楚。本研究评估了已确诊CVD的非糖尿病患者中的这种关系。
纳入前瞻性UCC-SMART队列中已确诊CVD但基线时无DM或HF的患者(n = 4653)。根据成人治疗小组III标准定义MetS。使用胰岛素抵抗稳态模型(HOMA-IR)量化胰岛素抵抗。结局为首次因HF住院。使用针对已确定的危险因素(年龄、性别、既往心肌梗死(MI)、吸烟、胆固醇和肾功能)进行调整的Cox比例风险模型评估关系。
在中位随访8.0年期间,观察到290例新发HF病例(0.81/100人年)。MetS与新发HF风险增加显著相关,独立于已确定的危险因素(风险比[HR] 1.32;95%置信区间[CI] 1.04 - 1.68,每个标准的HR 1.17;95% CI 1.06 - 1.29),HOMA-IR也是如此(每标准差[SD]的HR 1.15;95% CI 1.03 - 1.29)。在MetS的各个组成部分中,只有较高的腰围独立增加了HF风险(每SD的HR 1.34;95% CI 1.17 - 1.53)。这些关系独立于中期DM和MI的发生,并且对于射血分数降低与保留的HF而言无显著差异。
在目前未诊断为DM的CVD患者中,MetS和胰岛素抵抗独立于已确定的危险因素增加了新发HF的风险。